BAYN.DE · BAYER AG NA O.N.
Germany · RS rating 48 · As of 2026-10-14
| Price | 45.07 EUR |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 20 / 35 / 90 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 42 / 54 / 46 |
| Industry group (rank) | Medical-Generic Drugs (–) |
| EPS growth Q/Q | -91.8% |
| Sales growth Q/Q | -18.9% |
| Distance from 52-week high | +15.5% |
| Market cap (USD) | $48.1B |